Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study

Am J Hematol. 2011 Aug;86(8):709-10. doi: 10.1002/ajh.22071.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation / adverse effects
  • Female
  • Graft vs Host Disease / epidemiology
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Myeloablative Agonists / administration & dosage
  • Myeloablative Agonists / adverse effects*
  • Myeloablative Agonists / therapeutic use
  • Peripheral Blood Stem Cell Transplantation / adverse effects
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Recurrence
  • Retrospective Studies
  • Survival Analysis
  • Sweden / epidemiology
  • Time Factors
  • Transplantation, Homologous
  • Young Adult

Substances

  • Myeloablative Agonists